Cardiovascular Systems, Inc. (ticker: CSII, exchange: Privately Held)
News Release -
7-Sep-2010
Cardiovascular Systems to Present at Two September Investor
ConferencesRobert W. Baird Health Care Conference on Tuesday, September 14 at
10 a.m. ET
Fifth Annual JMP Securities Health Care Conference on Tuesday,
September 28 at 1 p.m. ET
Live Webcasts Available for Both Conferences
ST. PAUL, Minn., Sep 07, 2010 (BUSINESS WIRE) -- Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company
developing and commercializing innovative, interventional treatment
systems for vascular disease, will present at two upcoming health care
conferences in New York: the Robert W. Baird Health Care Conference at
the St. Regis New York, and the Fifth Annual JMP Securities Health Care
Conference at the New York Palace. President and Chief Executive Officer
David L. Martin and Chief Financial Officer Laurence L. Betterley will
provide an overview of the company and its growth opportunities.
|
|
|
|
|
|
WHEN:
|
|
|
|
Robert W. Baird Health Care Conference
|
|
|
|
|
Tuesday, Sept. 14; 10 a.m. EST
|
|
|
|
|
St. Regis New York
|
|
|
|
|
New York
|
|
|
|
|
|
Fifth Annual JMP Securities Health Care Conference
|
|
|
|
|
Tuesday, Sept. 28; 1 p.m. EST
|
|
|
|
|
New York Palace
|
|
|
|
|
New York
|
|
|
WEBCAST:
|
|
|
|
To listen to a live webcast of either presentation, go to the
investor information section of the company's Web site, www.csi360.com,
and click on the respective webcast icon.
|
|
|
|
|
|
If you have any difficulty accessing the webcast, please contact
Mick Forgey: (612) 455-1789; mforgey@psbpr.com
|
|
|
|
|
|
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical
device company focused on developing and commercializing interventional
treatment systems for vascular disease. The company's Diamondback 360(R)
and Diamondback Predator 360(TM) PAD Systems treat calcified and fibrotic
plaque in arterial vessels throughout the leg in a few minutes of
treatment time, and address many of the limitations associated with
existing surgical, catheter and pharmacological treatment alternatives.
As many as 12 million Americans suffer from peripheral arterial disease
(PAD), which is caused by the accumulation of plaque in peripheral
arteries (commonly the pelvis or leg) reducing blood flow. Symptoms
include leg pain when walking or at rest, and can lead to tissue loss
and eventually limb amputation. In August 2007, the U.S. FDA granted
510(k) clearance for the use of the Diamondback 360° as a therapy for
PAD, and CSI commenced a U.S. product launch in September 2007. Since
then, nearly 30,000 procedures have been performed using the Diamondback
360° in leading institutions across the United States. For more
information visit the company's Web site at www.csi360.com.
SOURCE: Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc.
Investor Relations, 651-259-2800
or
Padilla Speer Beardsley
Nancy A. Johnson, 612-455-1745
njohnson@psbpr.com |
Cardiovascular Systems, Inc.
